Abstract:(See the Editorial Commentary by Arend and Soolingen on pages 228–32.) Background. Understanding the transmission of Mycobacterium tuberculosis is essential for the development of efficient tuberculosis control strategies. China has the second-largest tuberculosis burden in the world. Recent transmission and infection with M. tuberculosis, particularly drug-resistant strains, may account for many new tuberculosis cases. Methods. We performed a population-based molecular epidemiologic study of pulmonary tuberculosis in China during 1J uly 2009 to 30 June 2012. We de fined clusters as cases with identical variable number tandem repeat genotype patterns and identified the risk factors associated with clustering, by logistic regression. Relative transmission rates were estimated by the sputum smear status and drug susceptibility status of tuberculosis patients. Results. Among 2274 culture-positive tuberculosis patients with genotyped isolates, there were 705 (31.0%) tuberculosis patients in 287 clusters. Multidrug-resistant (MDR) tuberculosis (adjusted odds ratio [aOR], 1.86; 95% confidence interval [CI], 1.25–2.63) and infection with a Beijing family strain (aOR, 1.56; 95% CI, 1.23– 2.96) were associated with clustering. Eighty-four of 280 (30.0%) clusters had a putative source case that was sputum smear negative, and 30.6% of their secondary cases were attributed to transmission by sputum smear–negative patients. The relative transmission rate for sputum smear negative compared with sputum smear–positive patients was 0.89 (95% CI, .68–1.10), and was 1.51 (95% CI, 1.00–2.24) for MDR tuberculosis vs drug-susceptible tuberculosis. Conclusions. Recent transmission of M. tuberculosis, including MDR strains, contributes substantially to tuberculosis disease in China. Sputum smear–negative cases were responsible for at least 30% of the secondary cases. Interventions to reduce the transmission of M. tuberculosis should be implemented in China.

The progress of serological diagnosis of tuberculosis

Global tuberculosis control: achievements, progress and new developments

Study progress of monocyte chemoattractant protein-1 in tuberculosis and HIV co-infected patients

Effectiveness and safety of preventive usage of liver protective drugs during anti-tuberculosis therapy: a systematic review of clinical trials in China

Epidemic Trends of Tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study.

Research on expression of Th1 and Th2 lymphocytes in sputum positive pulmonary tuberculosis and coinfection with HIV patients

Diagnosis and treatment for mycobacterium tuberculosis in human immunodeficiency virus-infected patients

Tuberculosis in China: A longitudinal predictive model of the general population and recommendations for achieving WHO goals.

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.

The current progress of the diagnosis and treatment for Mycobacterium tuberculosis infection among AIDS patients

Clinical epidemiology of 359 cases of acquired immunodeficiency syndrome and pulmonary tuberculosis co-infection

A clinical analysis of post-renal transplant pulmonary infection

Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021

The Hidden Threat of Subclinical Tuberculosis

In-hospital Mortality and Causes of Death in People Diagnosed With HIV in a General Hospital in Shenyang, China: A Cross-Sectional Study

Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021

Progress in tuberculosis control and the evolving public-health system in China.

Tuberculosis: Current state of knowledge: An Epilogue

Transmission of Tuberculosis in China: a Population-Based Molecular Epidemiology Study

New progress in the diagnosis of childhood tuberculosis

Transmission Ofmycobacterium Tuberculosisin China: A Population-Based Molecular Epidemiologic Study